In a latest research, we described the identification along with the characterization of a brand new atypical opioid receptor with distinctive adverse regulatory properties in the direction of opioid peptides.1 Our final results confirmed that ACKR3/CXCR7, hitherto known as an atypical scavenger receptor for chemokines CXCL12 and CXCL11, can https://norwichr691awt1.blogozz.com/profile